Copyright: ©Author(s) 2026.
World J Stem Cells. Sep 26, 2026; 18(9): 125409
Published online Sep 26, 2026. doi: 10.4252/wjsc.125409
Published online Sep 26, 2026. doi: 10.4252/wjsc.125409
Figure 2 Strategies for lung organoid construction and disease modeling.
This figure presents a proposed conceptual workflow for generating lung organoids from different stem cell sources and their application in modeling pulmonary diseases. 3D: Three-dimensional; AT2: Alveolar type 2; αSMA: Alpha-smooth muscle actin; COL1A1: Collagen type 1 alpha 1; COPD: Chronic obstructive pulmonary disease.
- Citation: Yang LY, Xing YF, Chen JY, Cao ZM, Ye H. Lung organoids for preclinical evaluation of stem cell therapies: Opportunities, evidence, and translational challenges. World J Stem Cells 2026; 18(9): 125409
- URL: https://www.wjgnet.com/1948-0210/full/v18/i9/125409.htm
- DOI: https://dx.doi.org/10.4252/wjsc.125409